NCT05279924View on ClinicalTrials.gov

Outcomes of Prophylaxis With Emicizumab in Children With Severe Hemophilia A in Ivory Coast

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

October 20, 2022

Study Completion Date

October 20, 2022

Conditions
Hemophilia A
Interventions
DRUG

Prophylaxis with Emicizumab

Prophylaxis with Emicizumab in Ivoirian boys with severe hemophilia A

Trial Locations (1)

Unknown

CHU de Yopougon, Abidjan

All Listed Sponsors
lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER